EARLY BREAST CANCER
Clinical trials for EARLY BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new EARLY BREAST CANCER trials appear
Sign up with your email to follow new studies for EARLY BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for breast cancer patients who Can't tolerate standard hormone therapy
Disease control Not yet recruitingThis study tests a new hormone therapy called giredestrant in 300 women with early-stage, hormone-sensitive breast cancer who had side effects from standard aromatase inhibitors. The goal is to see if patients stick with the treatment and how it affects their symptoms and quality…
Matched conditions: EARLY BREAST CANCER
Phase: PHASE3 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
Could a genetic test spare younger breast cancer patients from chemo?
Disease control Not yet recruitingThis study tests whether a genetic test (Prosigna®) can help decide if younger women with early, hormone-sensitive breast cancer need chemotherapy. Around 3,380 premenopausal women will be randomly assigned to either standard treatment (always chemo) or a test-guided approach tha…
Matched conditions: EARLY BREAST CANCER
Phase: PHASE3 • Sponsor: UNICANCER • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
Massive korean study tracks breast cancer recurrence in 100,000 patients
Knowledge-focused Not yet recruitingThis study will look back at the medical records of about 100,000 people in Korea who had early-stage, hormone receptor-positive, HER2-negative breast cancer and had surgery. The goal is to see how often the cancer returns or spreads, and what factors might affect that risk. No n…
Matched conditions: EARLY BREAST CANCER
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated May 01, 2026 16:01 UTC